scholarly journals Safety Profile of Tissue Plasminogen Activator Treatment Among Stroke Patients Carrying a Common Polymorphism (C-1562T) in the Promoter Region of the Matrix Metalloproteinase-9 Gene

Stroke ◽  
2003 ◽  
Vol 34 (12) ◽  
pp. 2851-2855 ◽  
Author(s):  
Joan Montaner ◽  
Israel Fernández-Cadenas ◽  
Carlos A. Molina ◽  
Jasone Monasterio ◽  
Juan F. Arenillas ◽  
...  
Keyword(s):  
Matrix Metalloproteinase ◽  
Plasminogen Activator ◽  
Tissue Plasminogen Activator ◽  
Safety Profile ◽  
Promoter Region ◽  
Stroke Patients ◽  
Common Polymorphism ◽  
Tissue Plasminogen ◽  
The Matrix ◽  
Metalloproteinase 9

scholarly journals Reduction of Tissue Plasminogen Activator-Induced Matrix Metalloproteinase-9 by Simvastatin in Astrocytes

Stroke ◽  
2006 ◽  
Vol 37 (7) ◽  
pp. 1910-1912 ◽  
Author(s):  
Sophia Wang ◽  
Sun-Ryung Lee ◽  
Shu-Zhen Guo ◽  
Woo Jean Kim ◽  
Joan Montaner ◽  
...  
Keyword(s):  
Matrix Metalloproteinase ◽  
Plasminogen Activator ◽  
Tissue Plasminogen Activator ◽  
Matrix Metalloproteinase 9 ◽  
Tissue Plasminogen ◽  
Metalloproteinase 9

scholarly journals The Impact of Loading Dose on Outcome in Stroke Patients Receiving Low-Dose Tissue Plasminogen Activator Thrombolytic Therapy

2020 ◽  
Vol Volume 14 ◽  
pp. 257-263 ◽  
Author(s):  
Yi-Sin Wong ◽  
Sheng-Feng Sung ◽  
Chi-Shun Wu ◽  
Yung-Chu Hsu ◽  
Yu-Hsiang Su ◽  
...  
Keyword(s):  
Thrombolytic Therapy ◽  
Plasminogen Activator ◽  
Tissue Plasminogen Activator ◽  
Low Dose ◽  
Loading Dose ◽  
Stroke Patients ◽  
Tissue Plasminogen ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document